Human Tissue Act 2004
Human Tissue Act 2004 is a piece of legislation enacted by the UK Parliament. It was designed to regulate the removal, storage, use and disposal of human bodies, organs and tissue. The Act was passed in response to public concern following high-profile scandals involving the retention of organs and tissues from deceased children by hospitals.
Background[edit]
The Human Tissue Act 2004 was introduced following the public outcry over the Alder Hey organs scandal, where organs from deceased children were retained by the Alder Hey Children's Hospital without the consent of the parents. This led to a public inquiry, the Redfern Report, which recommended changes to the law regarding the use of human tissue.
Provisions[edit]
The Act sets out a regulatory framework for the removal, storage, use and disposal of human bodies, organs and tissues. It established the Human Tissue Authority (HTA) to oversee these activities. The Act also makes it a criminal offence to remove, store or use human tissue without appropriate consent.
Consent[edit]
Under the Act, consent is the fundamental principle. It is unlawful to remove, store or use human tissue from a deceased person without appropriate consent. This can be given by the person themselves before they die, or by a nominated representative or a person in a qualifying relationship.
Regulation[edit]
The Act established the Human Tissue Authority (HTA) to regulate activities concerning the removal, storage, use and disposal of human tissue. The HTA is responsible for licensing organisations that carry out these activities.
Impact[edit]
The Human Tissue Act 2004 has had a significant impact on medical research, clinical practice and the public's trust in the healthcare system. It has led to greater transparency and accountability in the use of human tissue, and has helped to restore public confidence following the scandals of the past.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
